/Investor DB

3H Health Investment

Venture capital

Shanghai · Series A–Late Stage

Find your way into 3H Health Investment

Sign up to see every warm intro you have to 3H Health Investment

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the 3H Health Investment team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

3H Health Investment (Sanzheng Health Investment) is a Chinese healthcare-focused investment firm that partners with entrepreneurs to build leading companies in niche industry segments.

Source: firm website, verified Aug 3, 2026.

Stage
Series A–Late Stage
HQ
Shanghai, CN
Instruments
Equity
Founded
2016
Tracked investments
3

What they invest in

from 3 of 3 portfolio companies

Biotech ×3Healthtech ×3Deep Tech ×2AI & Machine Learning ×1Digital Health ×1Medical Devices ×1

HQs:China×2

Investments · 3 tracked

founders shown can be your intro path

By year:2022 · 12021 · 23 dated

Alebundalebund.cominSep 2021 · $54.5M

An innovative biopharmaceutical company focused on developing therapies for chronic kidney disease across multiple clinical stages, with a pipeline of eight products covering conditions such as hyperphosphatemia, renal anemia, IgA nephropathy, and diabetic kidney disease.

BiotechDigital HealthHealthtechMedical DevicesShanghai, CN

Co-investorsLAVLilly Asia VenturesQuan Capital3E Bioventures CapitalSherpa Healthcare PartnersYuanBio Venture Capital

EdiGeneedigene.comApr 2021 · $62M

EdiGene is a biotechnology company developing genome-editing-based therapies, including allogeneic cell therapies and in vivo RNA base editing platforms, alongside a high-throughput genome editing screening platform.

BiotechDeep TechHealthtech

Co-investorsLAVLilly Asia VenturesWI Harper GroupAlwin CapitalBioTrack CapitalIDG Capital+2 more

Therornatherorna.comJun 2022 · $42M

Therorna develops circular RNA-based therapeutic candidates and preventive medicines for diseases with unmet clinical needs.

AI & Machine LearningBiotechDeep TechHealthtechBeijing, CN

Co-investorsCenova CapitalQuan CapitalMSA CapitalSherpa Healthcare Partners

Frequently asked questions

What stage does 3H Health Investment invest at?
3H Health Investment invests at the Series A, Series B, Series C, Late Stage stages.
What sectors does 3H Health Investment focus on?
3H Health Investment focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is 3H Health Investment located?
3H Health Investment is headquartered in Shanghai, CN.

Similar investors

Featured in lists